Ellen S. Rosenberg serves as the Chief Legal Officer and Corporate Secretary at Amicus Therapeutics Inc., a position she has held with distinction since joining the company. With a robust background in corporate law and a keen understanding of the biotechnology industry, Rosenberg has been instrumental in guiding Amicus through complex legal landscapes and ensuring the company's compliance with regulatory standards. Her role involves overseeing all legal matters, including intellectual property, corporate governance, and strategic transactions, which are critical to the company's growth and success in developing treatments for rare diseases. Prior to her tenure at Amicus Therapeutics, Rosenberg held significant legal positions at several prominent organizations. She previously served as Senior Vice President, General Counsel, and Corporate Secretary at NPS Pharmaceuticals, where she played a pivotal role in the company's strategic initiatives and eventual acquisition. Her career also includes time at Paul, Weiss, Rifkind, Wharton & Garrison LLP, where she honed her skills in corporate law and mergers and acquisitions. Rosenberg's extensive experience and strategic legal acumen have been vital in her current role at Amicus, where she continues to drive the company forward with her leadership and expertise. Rosenberg's achievements extend beyond her professional roles, as she is also recognized for her contributions to the broader legal and biotechnology communities. She is a frequent speaker at industry conferences and has been involved in various professional organizations, further solidifying her reputation as a thought leader in her field. At Amicus Therapeutics, she not only manages the legal aspects of the company but also plays a crucial role in its corporate governance, ensuring that the company adheres to the highest standards of ethical conduct and transparency. Her dedication to advancing Amicus's mission to develop innovative therapies for rare diseases underscores her commitment to making a meaningful impact on patients' lives.